1093-P: Incidence of Primary Nonadherence to Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Agonists (GLP-1A) in an Integrated Health Care System

Background: The incidence and predictors of primary nonadherence (when a medication is prescribed but not dispensed) for newer glucose lowering medications including SGLT2i and GLP-1a is not known. Methods: Using a database that links electronic health records with commercial claims from an integrat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser:	LUO, JING, FELDMAN, ROBERT, ROTHENBERGER, SCOTT D., FISCHER, MICHAEL, KORYTKOWSKI, MARY T., GELLAD, WALID F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Agonists Creatinine Diabetes Diabetes mellitus Electronic medical records GLP-1 receptor agonists Glucagon Glucagon-like peptide 1 Glucose Health care Morbidity Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!